510(k) K253674
K253674 is an FDA 510(k) premarket notification submitted by Stryker Corporation (Tornier, S.A.S.) for the device "Blueprint Patient-Specific Instrumentation". The FDA issued a decision of Substantially Equivalent on April 3, 2026. The device falls under product code PHX (Shoulder Prosthesis, Reverse Configuration), a Class II device regulated under 21 CFR 888.3660. Stryker Corporation (Tornier, S.A.S.) has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 3, 2026
- Date Received
- November 21, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Shoulder Prosthesis, Reverse Configuration
- Device Class
- Class II
- Regulation Number
- 888.3660
- Review Panel
- OR
- Submission Type
Intended to be used to relieve pain and to replace the glenoid and humeral side of the shoulder joint in order to restore mobility in a grossly rotator cuff deficient joint with severe arthropathy or a previous joint replacement with a grossly rotator cuff deficient joint.